Literature DB >> 28092115

Fecal calprotectin level in healthy children aged less than 4 years in South Korea.

Joo Young Song1, Yoo Mi Lee1, You Jin Choi1, Su Jin Jeong1.   

Abstract

BACKGROUND: Fecal calprotectin (FC) is non-invasive inflammatory marker indicating various bowel diseases. However, the median-specific cut-off values and the standard deviations (SD) of the FC levels in each age group <4 years were not elucidated.
METHODS: Healthy volunteers were enrolled from four kindergartens. A questionnaire was used to confirm that the children met the inclusion criteria, and several demographics and history of bowel symptoms were collected. The FC level was measured.
RESULTS: A total of 234 healthy children aged between 6 months and 4 years were recruited. The median FC concentration of all participants was 245 μg/g (range 12-1033 μg/g, mean 68.5 μg/g, SD 123.12 μg/g). The children were divided into six age groups. The upper limit of 95% CI of median FC values was 135 μg/g in 7-12 months group, 65 μg/g in 13-18 months group, 55 μg/g in 19-24 months group, 40 μg/g in 25-30 months group, 21 μg/g in 31-36 months group, and 12 μg/g in 37-48 months group. A negative correlation trend was found between the age and the FC concentration.
CONCLUSION: This is the first study to present the FC median levels in the specific age groups <4 years in Korea. We found a FC level reduction with age, indicating a bowel maturation process and decreased intestinal permeability of the intestinal mucosa. In our study, FC levels reached the values of 50 μg/g around the age of 2 years.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  South Korea; calprotectin; gut maturation; infant; reference values

Mesh:

Substances:

Year:  2017        PMID: 28092115      PMCID: PMC6817235          DOI: 10.1002/jcla.22113

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  27 in total

1.  Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.

Authors:  S K Bunn; W M Bisset; M J Main; B E Golden
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-02       Impact factor: 2.839

2.  Fecal calprotectin level in healthy children aged less than 4 years in South Korea.

Authors:  Joo Young Song; Yoo Mi Lee; You Jin Choi; Su Jin Jeong
Journal:  J Clin Lab Anal       Date:  2017-01-16       Impact factor: 2.352

3.  Faecal calprotectin in children with chronic gastrointestinal symptoms.

Authors:  Alan Bremner; Sohere Roked; Rebecca Robinson; Ian Phillips; Mark Beattie
Journal:  Acta Paediatr       Date:  2005-12       Impact factor: 2.299

4.  Fecal calprotectin (FC) in newborns: is it a predictive marker of gastrointestinal and/or allergic disease?

Authors:  Maria E Baldassarre; Margherita Fanelli; Maria L Lasorella; Annamaria Laneve; Roberto Grosso; Maria R Falcone; Nicola Laforgia
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-07-05       Impact factor: 2.730

5.  Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.

Authors:  Ulrika Lorentzon Fagerberg; Lars Lööf; Johan Lindholm; Lars-Olof Hansson; Yigael Finkel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-10       Impact factor: 2.839

6.  Bifidobacterial succession and correlation networks in a large unselected cohort of mothers and their children.

Authors:  E Avershina; O Storrø; T Øien; R Johnsen; R Wilson; T Egeland; K Rudi
Journal:  Appl Environ Microbiol       Date:  2012-11-02       Impact factor: 4.792

7.  [Faecal calprotectin as an aid to the diagnosis of non-IgE mediated cow's milk protein allergy].

Authors:  Carlos Trillo Belizón; Eduardo Ortega Páez; Antonio F Medina Claros; Isabel Rodríguez Sánchez; Ana Reina González; Rafael Vera Medialdea; José Manuel Ramón Salguero
Journal:  An Pediatr (Barc)       Date:  2015-09-02       Impact factor: 1.500

8.  Can Fecal Calprotectin Level Be Used as a Markers of Inflammation in the Diagnosis and Follow-Up of Cow's Milk Protein Allergy?

Authors:  Omer F Beşer; Selim Sancak; Tülay Erkan; Tufan Kutlu; Haluk Cokuğraş; Fügen Ç Cokuğraş
Journal:  Allergy Asthma Immunol Res       Date:  2013-11-08       Impact factor: 5.764

9.  Fecal calprotectin levels are higher in rural than in urban Chinese infants and negatively associated with growth.

Authors:  Jin-Rong Liu; Xiao-Yang Sheng; Yan-Qi Hu; Xiao-Gang Yu; Jamie E Westcott; Leland V Miller; Nancy F Krebs; K Michael Hambidge
Journal:  BMC Pediatr       Date:  2012-08-23       Impact factor: 2.125

10.  Calprotectin could be a potential biomarker for acute appendicitis.

Authors:  Peter C Ambe; Daniel Gödde; Lars Bönicke; Marios Papadakis; Stephan Störkel; Hubert Zirngibl
Journal:  J Transl Med       Date:  2016-04-27       Impact factor: 5.531

View more
  5 in total

1.  Fecal calprotectin level in healthy children aged less than 4 years in South Korea.

Authors:  Joo Young Song; Yoo Mi Lee; You Jin Choi; Su Jin Jeong
Journal:  J Clin Lab Anal       Date:  2017-01-16       Impact factor: 2.352

2.  Effect of Supplementation of Zinc, Glutamine, Fiber, and Prebiotics in Presumed Healthy Indonesian Children Aged 1-3 Years.

Authors:  Muzal Kadim; Badriul Hegar; Saptawati Bardosono; Ina S Timan; Hartono Gunardi; Dwi Prasetyo; Agus Firmansyah; Yvan Vandenplas
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-07-03

3.  A Study of Fecal Calprotectin in Obese Children and Adults.

Authors:  Shin Young Park; Woo Jin Kim
Journal:  J Obes Metab Syndr       Date:  2018-12-30

4.  The perinatal factors that influence the excretion of fecal calprotectin in premature-born children.

Authors:  Jelena R Cekovic; Nikola S Prodanovic; Sara S Mijailovic; Sanja M Knezevic; Biljana P Vuletic; Andjelka K Stojkovic; Dragana M Savic; Tijana V Prodanovic; Marina M Stanojevic; Aleksandra M Simovic
Journal:  Open Med (Wars)       Date:  2022-07-13

5.  Dynamic Changes of Fecal Calprotectin and Related Clinical Factors in Neonates.

Authors:  Ji Sook Park; Jae Young Cho; Changyeong Chung; Seong Hee Oh; Hyun-Jeong Do; Ji-Hyun Seo; Jae Young Lim; Chan-Hoo Park; Hyang-Ok Woo; Hee-Shang Youn
Journal:  Front Pediatr       Date:  2020-07-08       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.